Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Contralateral ReSTOR / Monofocal or Phakic Eye
This study has been completed.
Sponsored by: Alcon Research
Information provided by: Alcon Research
ClinicalTrials.gov Identifier: NCT00731640
  Purpose

Bilateral evaluation of unilateral implantation of ReSTOR and contralateral monofocal or phakic eye.


Condition Intervention Phase
Cataracts
Device: ReSTOR
Phase IV

MedlinePlus related topics: Cataract
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Parallel Assignment
Official Title: Clinical Outcomes With AcrySof ReSTOR Aspheric Apodized Diffractive IOL in One Eye and a Contralateral Monofocal IOL or Phakic Eye

Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Visual Acuity [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Contrast Sensitivity, Patient Survey [ Time Frame: 6 Months ] [ Designated as safety issue: No ]

Enrollment: 52
Study Start Date: June 2007
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Monofocal: Active Comparator
Patients unilaterally implanted with ReSTOR lens in one eye and previously implanted with monofocal IOL (unspecified) in other eye
Device: ReSTOR
AcrySof ReSTOR +4 IOL unilaterally implanted
Phakic: Active Comparator
Patients unilaterally implanted with ReSTOR lens in one eye and phakic in the other eye with no necessary cataract removal impending
Device: ReSTOR
AcrySof ReSTOR +4 IOL unilaterally implanted

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Unilateral operable cataract
  • Candidate for presbyopic IOL

Exclusion Criteria:

  • Ocular comorbidities compromising primary outcome
  • Bilateral cataracts
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00731640

Locations
United States, Texas
Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
  More Information

Responsible Party: Alcon Research ( Rick Potvin/Director - Global Scientific Market Affairs )
Study ID Numbers: M07-012
Study First Received: August 7, 2008
Last Updated: August 8, 2008
ClinicalTrials.gov Identifier: NCT00731640  
Health Authority: United States: Institutional Review Board

Keywords provided by Alcon Research:
AcrySof ReSTOR Multifocal IOL

Study placed in the following topic categories:
Eye Diseases
Cataract
Lens Diseases

ClinicalTrials.gov processed this record on January 16, 2009